Cargando…

Alcohol reversibly disrupts TNF-α/TACE interactions in the cell membrane

BACKGROUND: Alcohol abuse has long been known to adversely affect innate and adaptive immune responses and pre-dispose to infections. One cellular mechanism responsible for this effect is alcohol-induced suppression of TNF-α (TNF) by mononuclear phagocytes. We have previously shown that alcohol in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Kejing, Zhao, Xue-Jun, Marrero, Luis, Oliver, Peter, Nelson, Steve, Kolls, Jay K
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1291403/ https://www.ncbi.nlm.nih.gov/pubmed/16246259 http://dx.doi.org/10.1186/1465-9921-6-123

Ejemplares similares

TNF-α signaling: TACE inhibition to put out the burning heart
por: Dittrich, Gesine M., et al.
Publicado: (2020)

Regulation of myogenic activation of p38 MAPK by TACE-mediated TNFα release
por: Li, Yi-Ping, et al.
Publicado: (2014)

Investigation of the Role of TNF-α Converting Enzyme (TACE) in the Inhibition of Cell Surface and Soluble TNF-α Production by Acute Ethanol Exposure
por: von Maltzan, Kristine, et al.
Publicado: (2012)

Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo
por: Wong, Eitan, et al.
Publicado: (2016)

Protective role of cellular prion protein against TNFα-mediated inflammation through TACE α-secretase
por: Ezpeleta, Juliette, et al.
Publicado: (2017)

Unlike for Human Monocytes after LPS Activation, Release of TNF-α by THP-1 Cells Is Produced by a TACE Catalytically Different from Constitutive TACE
por: Moreira-Tabaka, Helena, et al.
Publicado: (2012)

Focus On: Alcohol and the Immune System
por: Molina, Patricia E., et al.
Publicado: (2010)

Sitafloxacin reduces tumor necrosis factor alpha (TNFα) converting enzyme (TACE) phosphorylation and activity to inhibit TNFα release from lipopolysaccharide-stimulated THP-1 cells
por: Sakamaki, Ippei, et al.
Publicado: (2021)

The Role of Conventional TACE (cTACE) and DEBIRI-TACE in Colorectal Cancer Liver Metastases
por: Vogl, Thomas J., et al.
Publicado: (2022)

Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-α/TACE in focal cerebral ischemia in mice
por: Yang, Yi, et al.
Publicado: (2011)

TNFα cleavage beyond TACE/ADAM17: matrix metalloproteinase 13 is a potential therapeutic target in sepsis and colitis
por: Becker-Pauly, Christoph, et al.
Publicado: (2013)

TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma
por: Lu, Haohao, et al.
Publicado: (2023)

Transarterial Chemoembolization of Child-A hepatocellular carcinoma: Drug-eluting bead TACE (DEB TACE) vs. TACE with Cisplatin/Lipiodol (cTACE)
por: Wiggermann, Philipp, et al.
Publicado: (2011)

Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression
por: Zou, Xinhua, et al.
Publicado: (2021)

Immune modulation in the treatment of respiratory infection
por: Kolls, Jay K, et al.
Publicado: (2000)

Optimal interventional treatment for liver cancer: HAIC, TACE or iTACE?
por: Ge, Naijian, et al.
Publicado: (2023)

Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
por: Fan, Wenzhe, et al.
Publicado: (2021)

Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

DEB-TACE with irinotecan versus C-TACE for unresectable intrahepatic cholangiocarcinoma: a prospective clinical study
por: Wang, Junxiao, et al.
Publicado: (2023)

A Three-Gene Signature for Predicting the Prognosis of Patients Treated with Transarterial Chemoembolization (TACE) and Identification of PD-184352 as a Potential Drug to Reverse Nonresponse to TACE
por: Xia, Zicong, et al.
Publicado: (2022)

Anti-TNF-α therapy in membranous glomerulonephritis
por: Santoro, Domenico, et al.
Publicado: (2012)

Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

Immune Factor, TNFα, Disrupts Human Brain Organoid Development Similar to Schizophrenia—Schizophrenia Increases Developmental Vulnerability to TNFα
por: Benson, Courtney A., et al.
Publicado: (2020)

Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
por: Yao, Wang, et al.
Publicado: (2020)

Central role of the exchange factor GEF-H1 in TNF-α–induced sequential activation of Rac, ADAM17/TACE, and RhoA in tubular epithelial cells
por: Waheed, Faiza, et al.
Publicado: (2013)

Attenuation of Excess TNF-α Release in Crohn’s Disease by Silencing of iRHOMs 1/2 and the Restoration of TGF-β Mediated Immunosuppression Through Modulation of TACE Trafficking
por: Louis, Taylor J., et al.
Publicado: (2022)

The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
por: Kim, Jung Hee, et al.
Publicado: (2017)

TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial
por: Féray, Cyrille, et al.
Publicado: (2023)

Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease
por: Jiang, Hong, et al.
Publicado: (2011)

iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE
por: Oikonomidi, Ioanna, et al.
Publicado: (2018)

Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis
por: Scartozzi, Mario, et al.
Publicado: (2010)

The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular Carcinoma
por: Liu, Kang, et al.
Publicado: (2016)

Efficacy and Safety of TACE Combined with Regorafenib versus TACE in the Third-Line Treatment of Colorectal Liver Metastases
por: Lu, Haohao, et al.
Publicado: (2022)

Drug-eluting bead transarterial chemoembolization (TACE) vs conventional TACE in treating hepatocellular carcinoma patients with multiple conventional TACE treatments history: A comparison of efficacy and safety
por: Li, Hui, et al.
Publicado: (2019)

Actomyosin contractility confers mechanoprotection against TNFα-induced disruption of the intervertebral disc
por: Hernandez, Paula A., et al.
Publicado: (2020)

TNFα reverse signaling promotes sympathetic axon growth and target innervation
por: Kisiswa, Lilian, et al.
Publicado: (2013)

Procalcitonin Levels in Post TACE Infection
por: Han, Shugao, et al.
Publicado: (2020)

Transcatheter arterial chemoembolization (TACE) combined with γ-knife compared to TACE or γ-knife alone for hepatocellular carcinoma
por: Cai, Yeyu, et al.
Publicado: (2018)

Transcatheter arterial chemoembolisation (TACE) plus S-1 for the treatment of BCLC stage B hepatocellular carcinoma refractory to TACE
por: Huang, Wu-Kui, et al.
Publicado: (2017)

Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience
por: Abdelrahim, Maen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rtl1ce2nqlg7vfv5fl4glsrvc4